Efficacy and Safety of Intra-Articular Cell-Based Therapy for Osteoarthritis: Systematic Review and Network Meta-Analysis

Cartilage
Wei DingHong-Bo Tan

Abstract

Osteoarthritis (OA) is a chronic joint disease characterized by degeneration of articular cartilage and secondary osteogenesis. Cell-based agents, such as mesenchymal stem cells, have turned into the most extensively explored new therapeutic agents for OA. However, evidence-based research is still lacking. We searched public databases up to February 2020 and only included randomized controlled trials. The outcomes included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the Knee Injury and Osteoarthritis Outcome Score (KOOS), the visual analogue scale (VAS) score, and serious adverse events (SAEs). A network meta-analysis was also performed in this work. We included 13 studies in the meta-analysis. The effect size showed that cell-based therapy did not significantly reduce the WOMAC score at the 6-month follow-up (standard mean difference [SMD] -3.6; 95% confidence interval [CI] -0.90 to 0.18; P = 0.1928). However, cell-based therapy significantly improved the KOOS at the 12-month follow-up (SMD 0.68; 95% CI 0.07-1.30; P = 0.0288) and relieved pain (SMD -1.05; 95% CI -1.46 to -0.64; P < 0.0001). The findings also indicated that high-dosage adipose-derived mesenchymal stem cells (ADMSCs) may be more a...Continue Reading

References

Jun 13, 2003·Health and Quality of Life Outcomes·Ewa M Roos, Sören Toksvig-Larsen
Jul 19, 2008·Cell Biochemistry and Function·Yanxia ZhuZhanfeng Cui
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group
Dec 24, 2014·Nature Reviews. Rheumatology·Yangzi Jiang, Rocky S Tuan
Nov 25, 2016·Experimental and Therapeutic Medicine·Gang-Hua CuiWei-Shan Wang
Mar 5, 2017·British Journal of Sports Medicine·Haiko Imfl PasMaarten H Moen
May 18, 2017·Arthritis Care & Research·Lauren K KingGillian A Hawker
Aug 16, 2017·Proceedings of the National Academy of Sciences of the United States of America·Ian J WallaceDaniel E Lieberman
Nov 10, 2017·Nature Reviews. Rheumatology·Dennis McGonagleElena Jones
Apr 28, 2018·Statistics in Medicine·Robbie C M van Aert, Dan Jackson
Dec 8, 2016·Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery·Yali WangChunsheng Xiang
Jun 21, 2018·Stem Cell Research & Therapy·Samih Mohamed-AhmedShaza B Idris
Jul 17, 2018·PM & R : the Journal of Injury, Function, and Rehabilitation·Prathap JayaramGerard A Malanga
Sep 12, 2018·The Cochrane Database of Systematic Reviews·Marita S FønhusSigne A Flottorp
Oct 27, 2018·Orthopaedic Journal of Sports Medicine·Darby A HouckJonathan T Bravman
Nov 8, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Rui DongPinger Wang
Nov 21, 2018·Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association·Chul-Won HaHan-Jun Lee
May 18, 2019·The American Journal of Sports Medicine·Wenyan ZhouHongwei Ouyang
Aug 31, 2019·The Orthopedic Clinics of North America·Rushabh M VakhariaCarlos Jesus Lavernia
Dec 6, 2019·Frontiers in Bioengineering and Biotechnology·Kendrick ToWasim Khan
Jan 20, 2020·Research Synthesis Methods·Svenja E SeideMeinhard Kieser

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.